Genome-wide association studies have uncovered robust and reproducible associations between several genetic variations and the natural history of NAFLD. During this webinar, Professor Eric Trépo reviewed these findings that have provided compelling new insights into the biology of NAFLD and highlighted potentially attractive pharmaceutical targets. Professor Eric Trépo also discussed potential applications and limitations of genetic variations for risk prediction in this disease

Speaker: Prof. Eric Trépo
Host: Prof. Manuel Castro Cabezas
Co-host: Prof. Christophe Moreno